A novel role for an established player:: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia

被引：23

作者：

Ehrenreich, H ^{[1
]}

Timner, W ^{[1
]}

Sirén, AL ^{[1
]}

机构：

[1] Max Planck Inst Expt Med, D-37075 Gottingen, Germany

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2004年 / 31卷 / 01期

关键词：

D O I：

10.1016/j.transci.2004.05.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Erythropoietin, a hematopoietic growth-factor possessing manifold, potent neuroprotective properties, after multiple testing in cell culture and animal studies now gradually finds its way into clinical neuroscience. The first time this took place was in 1998 with a pilot study in stroke patients, the "Gottingen EPO-Stroke-Trial". This study was able to demonstrate that EPO is perfectly well tolerated and safe with this indication. Furthermore, the EPO-treated patients showed a significantly better outcome regarding their clinical progress as well as regarding the infarct size as observed by MRI, when compared to the placebo treated patients. At the moment a multicenter study is being carried out in Germany. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：39 / 44

页数：6

共 29 条

[21] Erythropoietin is a paracrine mediator of ischemic tolerance in the brain:: Evidence from an in vitro model [J].

Ruscher, K ;

Freyer, D ;

Karsch, M ;

Isaev, N ;

Megow, D ;

Sawitzki, B ;

Priller, J ;

Dirnagl, U ;

Meisel, A .

JOURNAL OF NEUROSCIENCE, 2002, 22 (23) :10291-10301

[22] Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells [J].

Shingo, T ;

Sorokan, ST ;

Shimazaki, T ;

Weiss, S .

JOURNAL OF NEUROSCIENCE, 2001, 21 (24) :9733-9743

[23] Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress [J].

Sirén, AL ;

Fratelli, M ;

Brines, M ;

Goemans, C ;

Casagrande, S ;

Lewczuk, P ;

Keenan, S ;

Gleiter, C ;

Pasquali, C ;

Capobianco, A ;

Mennini, T ;

Heumann, R ;

Cerami, A ;

Ehrenreich, H ;

Ghezzi, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :4044-4049

[24] Erythropoietin -: a novel concept for neuroprotection [J].

Sirén, AL ;

Ehrenreich, H .

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (04) :179-184

[25] Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain [J].

Sirén, AL ;

Knerlich, F ;

Poser, W ;

Gleiter, CH ;

Brück, W ;

Ehrenreich, H .

ACTA NEUROPATHOLOGICA, 2001, 101 (03) :271-276

[26] Erythropoietin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage originates from the brain [J].

Springborg, JB ;

Sonne, B ;

Frederiksen, HJ ;

Foldager, N ;

Poulsgaard, L ;

Klausen, T ;

Jorgensen, OS ;

Olsen, NV .

BRAIN RESEARCH, 2003, 984 (1-2) :143-148

[27] NEUROTROPHIC EFFECT OF HEMATOPOIETIC CYTOKINES ON CHOLINERGIC AND OTHER NEURONS IN-VITRO [J].

TABIRA, T ;

KONISHI, Y ;

GALLYAS, F .

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1995, 13 (3-4) :241-252

[28] Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis [J].

Villa, P ;

Bigini, P ;

Mennini, T ;

Agnello, D ;

Laragione, T ;

Cagnotto, A ;

Viviani, B ;

Marinovich, M ;

Cerami, A ;

Coleman, TR ;

Brines, M ;

Ghezzi, P .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) :971-975

[29] Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells [J].

Weishaupt, JH ;

Rohde, G ;

Pölking, E ;

Siren, AL ;

Ehrenreich, H ;

Bähr, M .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (05) :1514-1522

← 1 2 3 →